| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Gollob Jared is a Chief Medical Officer at Kymera Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $13.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 15,000 | $60.13 | $901,990.83 | -14.6% | -15.7% | -40.6% | |
| Feb 24, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Medical Officer | Sell | 37,064 | $50.68 | $1,878,355.25 | -17.1% | - | - | |
| Feb 19, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Medical Officer | Sell | 22,936 | $56.42 | $1,293,935.66 | -7.6% | - | - |